Published on 31 Jan 2025 on Zacks · via Yahoo Finance
AbbVie Beats on Q4 Earnings & Sales, Raises Sales View for Key Drugs
AbbVie Inc. ABBV reported fourth-quarter 2024 adjusted earnings of $2.16 per share, which beat the...
NYSE.ABBV price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free